| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 96,513 | 86,443 | 45,399 | 63,017 | | Cost of Revenue | 49,775 | 46,143 | 32,689 | 34,311 | | | Gross Profit | 46,738 | 40,300 | 12,710 | 28,706 | | | Operating Expenses | | Research Development | 12,514 | 10,901 | 12,621 | 12,114 | | Selling General and Administrative | 15,471 | 14,250 | 15,851 | 17,299 | | Non Recurring |
-
| (90) | 1,500 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 18,753 | 15,239 | (17,262) | (707) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (971) | 37 | 556 | 977 | | Earnings Before Interest And Taxes | 17,782 | 15,276 | (16,706) | 270 | | Interest Expense | (259) | 79 | 79 | 101 | | Income Before Tax | 18,041 | 15,197 | (16,785) | 169 | | Income Tax Expense | 5,871 | 6,183 | (6,672) | 53 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,170 | 9,014 | (10,113) | 116 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,170 | 9,014 | (10,113) | 116 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,170 | $9,014 | ($10,113) | $116 |
|
0.22% Nasdaq 
Income Statement
